Skip to main content

MoneyWorks4Me

Granules India informs about company updates

27 May 2019 Evaluate

Granules India has informed that Granules Pharmaceuticals, Inc. received US FDA approval for Methylphenidate Hydrochloride Extended-Release capsules.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..